10-K – 2026-02-11 – sitm-20251231.htm

12. Subsequent Events
On February 4, 2026, we entered into the Asset Purchase Agreement with Renesas, pursuant to which Renesas will and will cause certain of its affiliates to sell, transfer, assign and convey to SiTime all of their right, title and interest in, to and under certain assets related to the timing business of Renesas Electronics Corporation for an aggregate purchase price of approximately $ 1,500.0 million in cash and 4.13 million shares of our common stock, subject to certain adjustments as set forth in the Asset Purchase Agreement.
As described in greater detail in the Asset Purchase Agreement, the number of shares subject to the Stock Consideration will be determined based on the volume-weighted average price of our common stock for the period of 10 consecutive trading days ending on the third full trading day prior to the consummation of the Acquisition, subject to a floor price of $ 308.6686 and a ceiling price of $ 417.6104 .
The Closing is subject to the satisfaction of certain customary conditions, including the accuracy of each party’s representations and warranties as of the Closing, subject in certain instances, to certain materiality and other thresholds, the performance by each party of its obligations and covenants under the Asset Purchase Agreement in all material respects, the expiration or termination of the applicable waiting periods under HSR and the receipt of other governmental approvals in certain foreign jurisdictions.
Also on February 4, 2026, in connection with our entry into the Asset Purchase Agreement, we entered into the Commitment Letter with Wells Fargo, pursuant to which Wells Fargo has committed to provide us with debt financing to fund a portion of the Cash Consideration in an aggregate principal amount of up to $ 900.0  million in the form of the Bridge Facility, subject to customary conditions. Subject to market conditions and other factors, in lieu of all or a portion of the Bridge Facility, we may fund a portion of the acquisition consideration through one or more bank financing or capital markets transactions. The consummation of the acquisition is not conditioned on the availability of the Bridge Facility or any alternative financing.
88

Table of Contents

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
None.

Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures .
We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15 (e) and 15d – 15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), as appropriate, to allow for timely decisions regarding required disclosure.
Based on their evaluation as of the end of the period covered by this Annual Report on Form 10-K, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
The effectiveness of the Company's internal control over financial reporting as of December 31, 2025 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report and is incorporated herein by reference.
Management’s Annual Report on Internal Control over Financial Reporting; Attestation Report of the Registered Public Accounting Firm.
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets, (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2025 based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO. Based on our evaluation under the criteria set forth in Internal Control - Integrated Framework (2013) issued by the COSO, our management concluded our internal control over financial reporting was effective as of December 31, 2025.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

89

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the Board of Directors of SiTime Corporation
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of SiTime Corporation and subsidiaries (the "Company") as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) , the consolidated financial statements as of and for the year ended December 31, 2025, of the Company and our report dated February 11, 2026, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP

San Jose, California
February 11, 2026
90

Table of Contents

Item 9B. Other Information.
Trading Arrangements
During the Company's last fiscal quarter, the Company's following officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a "Rule 10b5-1 trading arrangement" (as defined in Item 408(a) of Regulation S-K of the Exchange Act) set forth in the table below, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c):

Name of the Director or Officer Designation of Director or Officer Action
Adoption/Termination Date
Rule 10b5-1 Expiration Date (1)
Number of securities to be sold
Lionel Bonnot Executive Vice President, Worldwide Sales and Business Development Adoption
November 15, 2025 X
August 21, 2026 16,816  
Fariborz Assaderaghi Executive Vice President, Engineering and Operations Adoption
November 14, 2025 X
July 31, 2026 12,923  
Piyush Sevalia Executive Vice President, Marketing Adoption
November 14, 2025 X
August 21, 2026 15,066  

(1) Each officer's trading arrangement terminates on the earliest of: (i) date stated above (ii) the first date on which all trades set forth in the trading arrangement have been executed, or (iii) such date the trading arrangement is otherwise terminated according to its terms.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not applicable.
91

Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance.
The information required by this item will be set forth under the captions “Election of Directors – Directors and Nominees” and “Election of Directors – Executive Officers, Directors and Director Nominees” in our definitive proxy statement to be filed with the SEC, in connection with our 2026 annual meeting of stockholders (the “Proxy Statement”), which is expected to be filed not later than 120 days after the end of our fiscal year ended December 31, 2025, and is incorporated in this report by reference.
Information regarding Section 16(a) beneficial reporting compliance, if any, will be set forth under the section entitled “Delinquent Section 16(a) Reports” in the Proxy Statement and is incorporated herein by reference.
We have adopted a Code of Business Conduct and Ethics that applies to all of our officers and employees, including our chief executive officer, chief financial officer, corporate controller, and other employees who perform financial or accounting functions. The Code of Business Conduct and Ethics sets forth the basic principles that guide the business conduct of our employees and is available on our website at www.sitime.com. We have also adopted a Code of Ethics for Senior Financial Officers that specifically applies to our chief executive officer (our principal executive officer), chief financial officer (our principal financial officer), and chief accounting officer (our principal accounting officer). Stockholders may request a free copy of our Code of Ethics for Senior Financial Officers by contacting us at SiTime Corporation, Attention: Investor Relations, 5451 Patrick Henry Drive, Santa Clara, California 95054.
To date, there have been no waivers under our Code of Business Conduct and Ethics or Code of Ethics for Senior Financial Officers. We will disclose on our website amendments to, or waivers from, our Code of Business Conduct and Ethics, in accordance with applicable laws and regulations.
The information concerning our Audit Committee and Audit Committee financial expert is incorporated by reference herein to the information set forth under the caption “Corporate Governance – Board Committee – Audit Committee” in our Proxy Statement.
Information regarding procedures by which stockholders may recommend nominees to our board of directors is set forth under the caption “Corporate Governance - Director Nominations” in the Proxy Statement.

Item 11. Executive Compensation.
The information required by this item will be set forth under the captions “Executive Compensation,” “Non-Employee Director Compensation,” "Corporate Governance," "Compensation Committee Interlocks and Insider Participation," and "Compensation Committee Report" in the Proxy Statement and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The information required by this item will be set forth under the caption “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information,” in the Proxy Statement and is incorporated herein by reference.
Equity Compensation Plan Information
The following table summarizes our equity compensation plan information as of December 31, 2025. Information is included for equity compensation plans approved by our stockholders as well as our 2022 Amended and Restated Inducement Award Plan (the “Inducement Plan”) adopted by our compensation committee without approval of our stockholders. The Inducement Plan provides for the grant of equity or equity-based awards in the form of non-qualified stock options, restricted stock units, and other stock-based awards. The Inducement Plan’s terms are substantially similar to the terms of SiTime’s 2019 Stock Incentive Plan, with the addition of certain terms and conditions intended to comply with the Nasdaq inducement award exception. Awards under the Inducement Plan may be granted only to employees who satisfy the standards for inducement grants under Rule 5635(c)(4) of the Nasdaq Listing Rules, and only when the award is
92

Table of Contents

an inducement material to such individual’s entering into employment with us, our subsidiaries or our affiliates within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.

Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted Average Exercise Price of Outstanding Options, Warrants and Rights (1)
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the first Column)
Equity compensation plans approved by stockholders (1)
1,018,687 $ —  2,237,006
Equity compensation plans not approved by stockholders (2)
262,701 —  176,524
Total 1,281,388 $ —  2,413,530

(1) Consists solely of our 2019 Stock Incentive Plan (the “2019 Stock Plan”). The 2019 Stock Plan contains an “evergreen” provision, pursuant to which the number of shares of common stock reserved for issuance pursuant to awards under such plan shall be increased on the first day of each year beginning in 2020, equal to the lesser of (i) 3% of the number of shares of common stock outstanding on the last day of the immediately preceding year, or (ii) if our Board acts prior to the first day of the year, such lesser amount that our Board determines for purposes of the annual increase of the year such number as determined by the plan administrator. As of January 1, 2026, the 2019 Stock Plan was increased by 788,965 shares pursuant to such evergreen provision. We have only granted RSUs from the 2019 Stock Plan, which have no exercise price.
(2) Consists solely of our Inducement Plan. We have only granted RSUs from the Inducement Plan, which have no exercise price.

Item 13. Certain Relationships and Related Transactions, and Director Independence.
The information required by this item will be set forth under the captions “Certain Relationships and Related Person Transactions” and “Corporate Governance — Director Independence” in the Proxy Statement and is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services.
The information required by this item will be set forth under the caption “Ratification of the Appointment of Independent Registered Public Accountants — Principal Accounting Fees and Services” in the Proxy and is incorporated herein by reference.
93

Table of Contents

PART IV

Item 15. Exhibits, Financial Statement Schedules.
(a) The following documents are filed as a part of this Annual Report on Form 10-K:
1. Financial Statements:

Consolidated Balance Sheets as of December 31, 2025 and 2024
61

Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2025, 2024, and 2023
62

Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2025, 2024, and 2023
63

Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024, and 2023
64

Notes to Consolidated Financial Statements
66

2. Financial Statement Schedule (Valuation and Qualifying Accounts) for the years ended December 31, 2025, 2024, and 2023:

Schedule II—Valuation and Qualifying Accounts
100

3. Exhibits:
The documents listed below are filed (or furnished, as noted) as exhibits to this Annual Report on Form 10-K:
94

Table of Contents

Exhibit Index

Incorporation by Reference
Exhibit
Number Exhibit Description Form File
Number Exhibit/Appendix
Reference Filing Date Filed
Herewith

2.1*
Asset Purchase Agreement, dated as of February 4, 2026, by and between SiTime Corporation and Renesas Electronics America Inc.
8-K 001-39135 2.1 2/4/2026

3.1 Restated Certificate of Incorporation of SiTime Corporation
8-K 001-39135 3.1 11/26/2019

3.2 Amended and Restated Bylaws of the Company
8-K 001-39135 3.2 6/29/2021

4.1 Form of Common Stock Certificate of the Company
S-1 333-234305 4.1 10/23/2019

4.2 Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
10-K 001-39135 4.2 2/16/2021

10.1+ Form of Indemnification Agreement between the Company and its directors and officers
10-K 001-39135 10.1 2/16/2021

10.2+ 2019 Stock Incentive Plan and Forms of Stock Option Agreement, Notice of Exercise, Stock Option Grant Notice, Restricted Stock Unit Agreement, and Restricted Stock Agreement thereunder
S-1 333-234305 10.2 10/23/2019

10.3+ New Terms of Employment, dated October 21, 2014, between Rajesh Vashist and the Company
S-1 333-234305 10.3 10/23/2019

10.4+ Amendment to Terms of Employment Letter, dated June 14, 2016, between Rajesh Vashist and the Company
S-1 333-234305 10.4 10/23/2019

10.5+ Offer of Employment, dated September 24, 2019, between Arthur D. Chadwick and the Company
S-1 333-234305 10.5 10/23/2019

10.6+ Offer of Employment, dated January 27, 2018, between Lionel Bonnot and the Company
S-1 333-234305 10.6 10/23/2019

10.7+ New Terms of Employment, dated October 20, 2014, between Piyush B. Sevalia and the Company
S-1 333-234305 10.7 10/23/2019

10.8+ Change of Control and Severance Agreement, between the Company and Rajesh Vashist
S-1 333-234305 10.8 10/23/2019

95

Table of Contents

10.9+ Form of Change of Control and Severance Agreement, between the Company and its Executives
S-1 333-234305 10.9 10/23/2019

10.12 Integration and Purchase Agreement, dated March 15, 2019, between the Company and MegaChips Corporation
S-1 333-234305 10.16 10/23/2019

10.13 Lease, dated April 15, 2016, between the Company and Batton Associates, LLC
S-1 333-234305 10.17 10/23/2019

10.14* License Agreement, dated August 1, 2018, between the Company and Robert Bosch LLC
S-1 333-234305 10.18 10/23/2019

10.15* Amended and Restated Manufacturing Agreement, dated February 23, 2017, between the Company and Robert Bosch LLC
S-1 333-234305 10.19 10/23/2019

10.16* Amendment No. 1 to Amended and Restated Manufacturing Agreement, dated August 1, 2018, between the Company and Robert Bosch LLC
S-1 333-234305 10.20 10/23/2019

10.18* Asset purchase agreement dated February 20, 2020, by and among MegaChips Taiwan Corporation and SiTime Corporation
10-Q 001-39135 10.2 5/7/2020

10.19+ Offer of Employment, dated June 5, 2020, between Vincent P. Pangrazio and SiTime Corporation
8-K 001-39135 10.1 6/9/2020

10.20+ Executive Bonus and Retention Plan
10-Q 001-39135 10.2 8/6/2020

10.21* Asset Purchase Agreement dated August 4, 2020, by and among MegaChips Corporation and SiTime Corporation
10-Q 001-39135 10.3 8/6/2020

10.22+ Offer of Employment dated November 16, 2020, between Fari Assaderaghi and SiTime Corporation
10-K 001-39135 10.22 2/16/2021

10.23+ Independent Director Compensation Policy
X

10.24+ Letter Agreement dated April 1, 2021 between Christine Heckart and SiTime Corporation
8-K 001-39135 10.1 4/5/2021

10.25+ Offer of Employment dated October 31, 2023, between Elizabeth Howe and SiTime Corporation
10-K 001-39135 10.25 2/26/2024

10.26+ Retirement Agreement dated October 30, 2023, between Arthur Chadwick and SiTime Corporation
10-K 001-39135 10.26 2/26/2024

96

Table of Contents

10.27 First Amendment to Lease, dated January 7, 2021, between Batton Associates, LLC and SiTime Corporation
10-Q 001-39135 10.1 11/4/2021

10.28+ Letter Agreement, dated October 18, 2021, between Rajesh Vashist and SiTime Corporation
10-K 001-39135 10.28 2/25/2022

10.29+ Amendment to Letter Agreement dated October 11, 2022, between Rajesh Vashist and SiTime Corporation
10-K
001-39145
10.29 2/27/2023

10.30+ Second Amendment to Letter Agreement dated October 11, 2022, between Rajesh Vashist and SiTime Corporation
10-K
001-39135 10.30 2/26/2024

10.31+
Third Amendment to Letter Agreement dated March 19, 2025, between Rajesh Vashist and SiTime Corporation
10-Q
001-39135 10.35 5/8/2025

10.32+
SiTime Corporation Amended and Restated 2022 Inducement Award Plan and Form of Restricted Stock Unit Agreement
10-K
001-39135 10.31 2/14/2025

10.33 Sales Agreement dated February 27, 2024 between SiTime Corporation and Stifel, Nicolaus & Company, Incorporated
8-K
001-39135 1.1 2/27/2024

10.34 Master Framework Agreement, dated as of October 30, 2023, by and between SiTime Corporation, Ningbo Aura Semiconductor Co., Ltd., Aura Semiconductor Pvt. Ltd., Shaoxing Yuanfang Semiconductor Co Ltd., Aura Semiconductor Limited, and Aim Core Holdings Limited.
8-K
001-39135
10.1 11/1/2023

10.35+
Offer of Employment dated April 21, 2015 between SiTime Corporation and Samsheer Ahmad
10-K 001-39135 10.34 2/26/2024

10.36 Commitment Letter, dated as of February 4, 2026, by and among SiTime Corporation, Wells Fargo Securities, LLC and Wells Fargo Bank, National Association.
8-K
001-39135
10.1 2/4/2026

10.37+
Letter Agreement, dated October 16, 2025, between SiTime Corporation and Mr. Ganesh Moorthy
8-K
001-39135
10.1 10/15/2025

10.38+
Letter Agreement, dated January 21, 2026, between SiTime Corporation and Mr. Faraj Aalaei
8-K
001-39135
10.1 1/21/2026

19.1 Insider Trading and Communications Policy
10-Q 001-39135 19.1 8/7/2025

97

Table of Contents

21.1 Subsidiaries of the Company
X

23.1 Consent of Deloitte & Touche LLP., Independent Registered Public Accounting Firm
X

23.2 Consent of BDO USA, P.C., Independent Registered Public Accounting Firm
X

24.1 Power of Attorney (see signature page hereto)
X

31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X

31.2 Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X

32.1# Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X

32.2# Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X

97.1 Incentive Compensation Recoupment Policy
10-K 001-39135 97.1 2/26/2024

101.INS XBRL Instance Document X
101.SCH XBRL Taxonomy Extension Schema Document X
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document X
101.DEF XBRL Taxonomy Extension Definition Linkbase Document X
101.LAB XBRL Taxonomy Extension Label Linkbase Document X
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document X

All references in the table above to previously filed documents or descriptions are incorporating those documents and descriptions by reference thereto.
All references to documents filed as exhibits to periodic reports are to periodic reports of SiTime Corporation, SEC File No. 001-39135.
______________
+ Indicates a management contract or compensatory plan.
* Portions of this exhibit have been omitted in accordance with Item 601 of Regulation S-K.
# In accordance with Item 601(b)(32)(ii) of Regulation S‑K and SEC Release No. 34‑47986, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10‑K and will not be deemed “filed” for purposes of
98

Table of Contents

Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933 except to the extent that the Company specifically incorporates it by reference.

Item 16. Form 10-K Summary.
None
99

Table of Contents

SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS

Valuation and Qualifying Accounts
Balance at
Beginning
of Period Additions
Charged to
Expenses or
Other Accounts Deductions
Credited to
Expenses or
Other Accounts Balance at
End of
Period
(in thousands)
Allowance for credit losses
Year Ended December 31, 2025 $ 50   $ —   $ —   $ 50  
Year Ended December 31, 2024 $ 50   $ —   $ —   $ 50  
Year Ended December 31, 2023 $ 50   $ —   $ —   $ 50  
Deferred tax valuation allowance
Year Ended December 31, 2025 $ 126,050   $ 10,344   $ —   $ 136,394  
Year Ended December 31, 2024 $ 105,772   $ 20,278   $ —   $ 126,050  
Year Ended December 31, 2023 $ 82,674   $ 23,098   $ —   $ 105,772  

100

Table of Contents

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized .

SiTime Corporation

Date: February 11, 2026
By: /s/ Elizabeth A. Howe

Elizabeth A. Howe

Executive Vice President, Chief Financial Officer

POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Rajesh Vashist and Elizabeth A. Howe, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place, or stead, in any and all capacities, to sign any and all amendments to this Report, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
101

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

Name Title Date

Chief Executive Officer and Director
/s/ Rajesh Vashist (Principal Executive Officer) February 11, 2026

Rajesh Vashist

Executive Vice President, Chief Financial Officer
/s/ Elizabeth A. Howe
(Principal Financial Officer)
February 11, 2026

Elizabeth A. Howe

Senior Vice President, Finance and Chief Accounting Officer

/s/ Samsheer Ahmad
(Principal Accounting Officer)
February 11, 2026

Samsheer Ahmad

/s/ Faraj Aalaei
Director February 11, 2026

Faraj Aalaei

/s/ Raman K. Chitkara Director February 11, 2026

Raman K. Chitkara

/s/ Edward H. Frank Director February 11, 2026

Edward H. Frank

/s/ Christine Heckart Director February 11, 2026

Christine Heckart

/s/ Torsten G. Kreindl Director February 11, 2026

Torsten G. Kreindl

/s/ Ganesh Moorthy
Director February 11, 2026

Ganesh Moorthy

/s/ Katherine E. Schuelke Director February 11, 2026

Katherine E. Schuelke

/s/ Akira Takata Director February 11, 2026

Akira Takata

102